Hextar Healthcare Berhad (KLSE:HEXCARE)

Hextar Healthcare Berhad Cash Flow Statement

Financials in millions MYR. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-43.93	-44.5	-13.92	-64.38	-55.69	185.74
Depreciation & Amortization	14.84	14.84	16.97	19.43	14.86	13.33
Other Amortization	0.08	0.08	0.33	0.33	0.33	-0.05
Loss (Gain) From Sale of Assets	0.09	0.09	0.19	1.22	0.03	-5.95
Asset Writedown & Restructuring Costs	10.48	10.48	0.27	8.58	20	0.42
Loss (Gain) From Sale of Investments	-0	-0	-	-0.02	0.02	-
Loss (Gain) on Equity Investments	2.7	2.7	2.34	0.09	-	-
Provision & Write-off of Bad Debts	1.05	1.05	-0.81	5.14	0.09	-
Other Operating Activities	24.43	22.38	10.66	11.92	4.92	-2.36
Change in Accounts Receivable	16.24	-0.82	-4.45	-0.17	7.78	31.22
Change in Inventory	19.83	16.17	-33.13	-5.35	15.96	-56.73
Change in Accounts Payable	-6.67	-3.1	1.85	-1.05	-19.05	-28.87
Change in Other Net Operating Assets	-0.41	-0.41	2.47	0.91	-9.57	-2.45
Operating Cash Flow	38.72	18.96	-17.24	-23.34	-20.31	134.31
Operating Cash Flow Growth	-	-	-	-	-	-4.97%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-6.3	-6.51	-5.15	-5.4	-14.65	-35.22
Sale of Property, Plant & Equipment	-1.06	0.13	0.48	1.28	0.15	-
Cash Acquisitions	-	-	-	-	-7.89	-
Divestitures	-	-	-	-	1.34	-
Investment in Securities	-8.13	-8.13	-12.9	-37.12	-142.86	-
Other Investing Activities	12.1	11.97	0.55	1.82	3.91	53.96
Investing Cash Flow	-3.38	-2.54	-17.02	-39.43	-160	18.74

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Issued	-	-	0.28	-	-	-
Total Debt Issued	-7.25	-	0.28	-	-	-
Short-Term Debt Repaid	-	-	-	-	-	-0.23
Long-Term Debt Repaid	-	-2.43	-2.26	-3.29	-1.2	-4.35
Total Debt Repaid	-2.52	-2.43	-2.26	-3.29	-1.2	-4.58
Net Debt Issued (Repaid)	-9.77	-2.43	-1.97	-3.29	-1.2	-4.58
Issuance of Common Stock	-	-	20.08	-	-	78.16
Repurchase of Common Stock	-	-	-	-	-23.99	-32.69
Other Financing Activities	-0.49	-0.56	-0.54	-0.82	-0.6	-0.52
Financing Cash Flow	-10.26	-2.98	17.57	-4.11	-25.79	40.37

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-0.62	0.18	-0.17	0.21	0.06	-0.13
Net Cash Flow	24.46	13.62	-16.85	-66.68	-206.04	193.29

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	32.43	12.44	-22.39	-28.74	-34.96	99.09
Free Cash Flow Growth	-	-	-	-	-	24.33%
Free Cash Flow Margin	22.55%	8.28%	-14.97%	-18.32%	-19.38%	19.25%
Free Cash Flow Per Share	0.03	0.01	-0.02	-0.03	-0.04	0.12
Levered Free Cash Flow	58.04	27.74	9.46	-39.35	-47.03	61.3
Unlevered Free Cash Flow	58.2	27.94	9.62	-39.04	-46.91	61.36

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	0.49	0.56	0.54	0.82	0.6	0.52
Cash Income Tax Paid	-	-9.16	2.94	9.22	15.57	49.7
Change in Working Capital	28.99	11.84	-33.26	-5.66	-4.88	-56.82

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error